APPLICATIONS PUBLISHED 20 SEPTEMBER 2005

Novel drug compsns and dosage forms of topiramate
Alza Crop 1701697*

Directly compressible pharmaceutical compsn for the oral administration of CCI-779
Wyeth 1701698*

Pharmaceutical compsn
Schering 1701699*

Compsns comprising memantine and polyanionic polymers for administration to the eye
Allergan 1701700*

Methods for preparing a foam comprising a sclerosing agent
BTG International 1701701*

Spray-congeal process using an extruder for preparing multiparticulate azithromycin compsns containing preferably a poloxamer and a glyceride
Pfizer Products 1701702*

Stabilised pharmaceutical solid compsns of low-solubility drugs, poloxamers and stabilising polymers
Pfizer Products 1701703*

Solid compsns of low-solubility drugs and poloxamers
Pfizer Products 1701704*

Enhanced absorption of modified release dosage forms
Advancis Pharmaceutical Corp 1701705*

Novel drug compsns and dosage forms
Alza Crop 1701706*

Drug granule coatings that impart smear resistance during mechanical compression
Alza Corp 1701707*

Novel drug compsns and dosage forms of topiramate
Alza Crop 1701708*

Confection product containing urea
WM Wrigley Jr Co 1701709*

Microemulsions for pharmaceutical compsns
Wyeth 1701710*

Nanoparticles for delivery of a pharmacologically active agent
Istituto Superiore di Sanita 1701711*

Oral medicament delivery system comprising collagen-based fibrous matrix
Pediamed Pharmaceuticals 1701712*

Coated fibrous nodules and insulation product
Johns Manville 1701713*

Improved sustained release compsns for pulmonary administration of insulin
Nektar Therapeutics 1701714*

Zeaxanthin formulations with additional ocular-active nutrient, for protecting eye health and treating eye disorders
Zeavision 1701715*

Antiaging compsn
Kaneka 1701716*

Method of treating elevated plasma homocysteine levels in ESRD patients
London Health Sciences Research Centre 1701717*

Substituted melatonin derivatives, process for their preparation, and methods of use
Abraxis Bioscience 1701718*

CHB-gemcitabin combined agent and use thereof as anti-tumoural active substances
Salama, Zoser 1701719*

Use of CHP as an inhibitor of glutathione S-transferases and collagen IV
Salama, Zoser 1701720*

Use of pilocarpine for hypoptyalism treatment
Perovitch, Philippe; Maury, Marc; Deymes, Jean 1701721*

N-hydroxy-4-(5-(4-(5-isopropyl-2-methyl-1m3-thiazol-4-yl)-phenoxy)pentoxy)benzamide 2 methansulphonic acid salt
Dong Wha Pharmaceutical 1701722*

Colon cleansing compsn and method
Abboud, Sernaan 1701723*

Alkylamino, arylamino, and sulphonamido cyclopentyl amide modulators of chemokine receptor activity
Merck 1701724*

Methods and compsns
CNSBIO 1701725*

Antimicrobial photodynamic therapy compound and method of use
CeramOptec 1701726*

Dutpase inhibitor
Medivir Aktiebolag 1701727*

Use of cathepsin Z inhibitors for the treatment of rheumatoid arthritis and other autoimmune diseases
Aventis Pharmaceuticals 1701728*

Improved bone matrix compsns and methods
Osteotech 1701729*

Method and vaccine comprising copolymer of psychiatric disorders
Yeda Research and Development Company 1701730*

GLP-1 (9-36) methods and compsns
Albert Einstein College of Medicine of Yeshiva University 1701731*

Sulphydryl protected glutathione prodrug
Nagasawa, Herbert 1701732*

Surface protection of exposed biological tissues
Bioactive Polymers 1701733*

Methods for treating vascular disorders
Allergan 1701734*

Use of hydroxylated amino acids for treating diabetes
Innodia 1701735*

Therapeutic agents and uses therefor
The Walter and Eliza Hall Institute of Medical Research 1701736*

Use of shigella invaplex to transport functional proteins and transcriptionally active nucleic acids across mammalian cell membranes in vitro and in vivo
The Government of the United States of America, as represented by the Secretary of the Army 1701737*

Method for producing storage stable virus and immunogenic compsns thereof
Wyeth 1701738*

Use of agents derived from CEACAM1 for the treatment of inflammatory diseases
Utku, Nalan 1701739*

Immunologic compounds for prevention, protection, prophylaxis or treatment of immunological disorders, infections and cancer
University of Montreal; Hospital Maisonneuve-Rosemont 1701740*